Research ArticleOriginal Article
Open Access

Evaluation of gene-gene interaction between the interleukin (IL)-2 and IL-2RA gene polymorphisms in schizophrenia patients in the Turkish Population

Kursat Ozdilli, Hasan Mervan Aytac, Fatima Ceren Tuncel, Yasemin Oyaci, Mustafa Pehlivan and Sacide Pehlivan
Neurosciences Journal January 2024, 29 (1) 51-56; DOI: https://doi.org/10.17712/nsj.2024.1.20230075

References

  1. 1.↵
    1. Aytac HM,
    2. Yazar MS,
    3. Erol A,
    4. Pehlivan S
    . Investigation of inflammation related gene polymorphism of the mannose-binding lectin 2 in schizophrenia and bipolar disorder. Neurosciences (Riyadh) 2021; 26: 346–356.
    OpenUrlAbstract/FREE Full Text
  2. 2.
    1. Goker M,
    2. Aytac HM,
    3. Guclu O
    . Evaluation of Serum Complement Levels and Factors Affecting Treatment Resistance in Patients with Schizophrenia. Psychiatry and Clinical Psychopharmacology 2023; 33: 84–93.
    OpenUrl
  3. 3.↵
    1. Pehlivana S,
    2. Aytacb HM,
    3. Ciftcia HS,
    4. Oyacia Y,
    5. Pehlivanc M,
    6. Nursal AF
    . Investigating the eNOS and IFN-γ gene variants susceptible to bipolar disorder or Schizophrenia in a Turkish cohort. Psychiatry And Clinical Psychopharmacology 2020; 30: 354–361.
    OpenUrl
  4. 4.↵
    1. Aytac HM,
    2. Oyaci Y,
    3. Yazar MS,
    4. Pehlivan S
    . Macrophage migration inhibitory factor-173 G/C polymorphism is associated with the age of onset and insight in Schizophrenia in the Turkish population. Neurol Res 2021; 43: 977–984.
    OpenUrl
  5. 5.↵
    1. Fineberg AM,
    2. Ellman LM
    . Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biological psychiatry 2013; 73: 951–966.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Heidari Nia M,
    2. Sargazi S,
    3. Saravani R,
    4. Mirinejad S,
    5. Jahantigh D,
    6. Shakiba M
    . Relationship between GABRB2 gene polymorphisms and schizophrenia susceptibility: a case-control study and in silico analyses. Int J Neurosci 2022; 132: 633–642.
    OpenUrl
  7. 7.
    1. Sargazi S,
    2. Nia MH,
    3. Sheervalilou R,
    4. Mirinejad S,
    5. Harati-Sadegh M,
    6. Moudi M, et al.
    Relationship between single nucleotide polymorphisms of GRHL3 and schizophrenia susceptibility: a preliminary case-control study and bioinformatics analysis. Int J Mol Cell Med 2020; 9: 154–164.
    OpenUrlCrossRef
  8. 8.↵
    1. Sargazi S,
    2. Mirani Sargazi F,
    3. Heidari Nia M,
    4. Sheervalilou R,
    5. Saravani R,
    6. Mirinejad S, et al.
    Functional variants of miR-143 are associated with schizophrenia susceptibility: a preliminary population-based study and bioinformatics analysis. Biochem Genet 2022: 1–14.
  9. 9.↵
    1. Allen NC,
    2. Bagade S,
    3. McQueen MB,
    4. Ioannidis JP,
    5. Kavvoura FK,
    6. Khoury MJ, et al.
    Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature genetics 2008; 40: 827–834.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Pehlivan S,
    2. Oyaci Y,
    3. Tuncel FC,
    4. Aytac HM
    . Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population. Egyptian Journal of Medical Human Genetics 2022; 23: 127.
    OpenUrl
  11. 11.
    1. Oyaci Y,
    2. Aytac HM,
    3. Pehlivan M,
    4. Pehlivan S
    . Genetic polymorphism of IL-17F rs763780 contributes to the susceptibility to bipolar disorder but not to schizophrenia in the Turkish population. Nucleosides Nucleotides Nucleic Acids 2023:42: 852–866.
    OpenUrl
  12. 12.↵
    1. Deverman BE,
    2. Patterson PH
    . Cytokines and CNS development. Neuron 2009; 64: 61–78.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Abbas AK,
    2. Trotta E,
    3. Simeonov DR,
    4. Marson A,
    5. Bluestone JA
    . Revisiting IL-2: Biology and therapeutic prospects. Sci Immunol 2018; 3: eaat1482.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Degrave W,
    2. Tavernier J,
    3. Duerinck F,
    4. Plaetinck G,
    5. Devos R,
    6. Fiers W
    . Cloning and structure of the human interleukin 2 chromosomal gene. The EMBO Journal 1983; 2: 2349–2353.
    OpenUrl
  15. 15.↵
    1. Kennedy JL,
    2. Basile VS,
    3. Macciardi FM,
    4. Detera-Wadleigh S,
    5. Evans K,
    6. Holmans P, et al.
    Chromosome 4 Workshop Summary: Sixth World Congress on Psychiatric Genetics, Bonn, Germany, October 6–10, 1998. Am J Med Genet 1999; 88: 224–228.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Mowry BJ,
    2. Ewen KR,
    3. Nancarrow DJ,
    4. Lennon DP,
    5. Nertney DA,
    6. Jones HL, et al.
    Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Am J Med Genet 2000; 96: 864–869.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Paunio T,
    2. Ekelund J,
    3. Varilo T,
    4. Parker A,
    5. Hovatta I,
    6. Turunen JA, et al.
    Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet 2001; 10: 3037–3048.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Gao QJ,
    2. Liu DW,
    3. Zhang SY,
    4. Jia M,
    5. Wang LM,
    6. Wu LH, et al.
    Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 2009; 15: 5610.
    OpenUrlPubMed
  19. 19.↵
    1. Paul-Samojedny M,
    2. Owczarek A,
    3. Kowalczyk M,
    4. Suchanek R,
    5. Palacz M,
    6. Kucia K, et al.
    Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFα) gene polymorphisms with paranoid schizophrenia in a Polish population. J Neuropsychiatry Clin Neurosci 2013; 25: 72–82.
    OpenUrl
  20. 20.↵
    1. Schwarz MJ,
    2. Krönig H,
    3. Riedel M,
    4. Dehning S,
    5. Douhet A,
    6. Spellmann I, et al.
    IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006; 256: 72–76.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Sawicka B,
    2. Borysewicz-Sańczyk H,
    3. Wawrusiewicz-Kurylonek N,
    4. Aversa T,
    5. Corica D,
    6. Gościk J, et al.
    Analysis of polymorphisms rs7093069-IL-2Ra, rs7138803-FAIM2, and rs1748033-PADI4 in the group of adolescents with autoimmune thyroid diseases. Front Endocrinol (Lausanne) 2020; 11: 544658.
    OpenUrl
  22. 22.↵
    1. Wang X-X,
    2. Chen T
    . Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk. Immunol Invest 2018; 47: 431–42.
    OpenUrlPubMed
  23. 23.↵
    1. Straub RE,
    2. MacLean CJ,
    3. Martin RB,
    4. Ma Y,
    5. Myakishev MV,
    6. Harris-Kerr C, et al.
    A schizophrenia locus may be located in region 10p15–p11. Am J Med Genet 1998; 81: 296–301.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Mousa SM,
    2. Makhlouf MM,
    3. Mohammed ET,
    4. Zawam HM
    . The influence of interleukin-2 gene polymorphisms on the risk and clinical outcome of non-Hodgkin lymphoma. Indian J Hematol Blood Transfus 2021; 37: 549–554.
    OpenUrl
  25. 25.↵
    1. Abou El Ella SS,
    2. Tawfik MA,
    3. Mohammed ZS,
    4. Barseem NF
    . PTPN22 gene and IL2RA rs11594656, rs2104286 gene variants: additional insights of polygenic single-nucleotide polymorphisms’ pattern among Egyptian children with type 1 diabetes. Egypt Pediatric Association Gaz 2021; 69: 1–9.
    OpenUrl
  26. 26.↵
    1. Lee WC,
    2. Wang LY
    . Simple formulas for gauging the potential impacts of population stratification bias. Am J Epidemiol 2008; 167: 86–89.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Ebrinc S,
    2. Top C,
    3. Öncül O,
    4. Başoğlu C,
    5. Çavuşlu Ş,
    6. Cetin M
    . Serum Interleukin 1α and Interleukin 2 Levels in Patients with Schizophrenia. Journal of international medical research 2002; 30: 314–317.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Chen L,
    2. Zheng WH,
    3. Du Y,
    4. Li XS,
    5. Yu Y,
    6. Wang H, et al.
    Altered peripheral immune profiles in first-episode, drug-free patients with schizophrenia: Response to antipsychotic medications. Front Med (Lausanne) 2021; 8: 757655.
    OpenUrl
  29. 29.↵
    1. Asevedo E,
    2. Rizzo LB,
    3. Gadelha A,
    4. Mansur RB,
    5. Ota VK,
    6. Berberian AA, et al.
    Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia. Physiol Behav 2014; 129: 194–198.
    OpenUrl
  30. 30.↵
    1. Zhang XY,
    2. Zhou DF,
    3. Cao LY,
    4. Zhang PY,
    5. Wu GY
    . Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia. J Psychiatr Res 2002; 36: 331–336.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Rapaport MH,
    2. McAllister CG,
    3. Pickar D,
    4. Tamarkin L,
    5. Kirch DG,
    6. Paul SM
    . CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers. Schizophr Res 1997; 25: 123–129.
    OpenUrlPubMed
  32. 32.
    1. O’Donnell MC,
    2. Catts SV,
    3. Ward PB,
    4. Liebert B,
    5. Lloyd A,
    6. Wakefield D, et al.
    Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res1996; 65: 171–178.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Huang Y,
    2. Zhang X,
    3. Zhou N
    . The Interrelation between Interleukin-2 and Schizophrenia. Brain Sci 2022; 12: 1154.
    OpenUrl
  34. 34.↵
    1. Palacz M,
    2. Paul-Samojedny M,
    3. Owczarek A,
    4. Kucia K,
    5. Kowalski J
    . T-330G IL-2 polymorphism in patients with paranoid schizophrenia. Farmaceutyczny Przeglad Naukowy 2010;7:23–7.
    OpenUrl
  35. 35.↵
    1. Hoffmann SC,
    2. Stanley EM,
    3. Cox ED,
    4. Craighead N,
    5. DiMercurio BS,
    6. Koziol DE, et al.
    Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes1. Transplantation 2001; 72: 1444–1450.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Hong J,
    2. Bang M
    . Anti-inflammatory strategies for schizophrenia: a review of evidence for therapeutic applications and drug repurposing. Clin Psychopharmacol Neurosci 2020; 18: 10–24.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section